Enteric Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The enteric nervous system (ENS) is often called the "second brain" due to its complex neural circuitry and neurotransmitter production capabilities. Enteric neurons control gastrointestinal motility, secretion, blood flow, and immune function, and increasingly recognized as playing a crucial role in neurodegenerative diseases through the Gut-Brain Axis[@ref]. The ENS contains approximately 200-600 million neurons organized into two major ganglionated plexuses: the myenteric (Auerbach's) plexus and the submucosal (Meissner's) plexus[^2].
Enteric neurons are particularly vulnerable in Parkinson's Disease through several key molecular pathways:
α-Synuclein Aggregation: The enteric nervous system is one of the earliest sites of alpha-synuclein pathology, with Lewy bodies detectable in enteric neurons years before CNS symptoms appear. This is linked to the gut-brain axis and protein aggregation pathways.
Neuroinflammation: Enteric neurons are surrounded by immune cells (macrophages, mast cells) that can become activated in response to pathogens or protein aggregates, releasing pro-inflammatory cytokines that damage neurons.
Mitochondrial Dysfunction: Like in Parkinson's Disease, enteric neurons show impaired mitochondrial complex I activity, linked to genes like C9orf72 and PINK1.
Oxidative Stress: The gut environment exposes enteric neurons to high levels of oxidative stress from dietary components, bacterial metabolites, and mitochondrial dysfunction.
Calcium Dysregulation: Enteric neurons rely heavily on calcium signaling for rhythmic activity; dysregulation triggers apoptosis.
These mechanisms are potential therapeutic targets for disease-modifying treatments in Parkinson's Disease.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0007011 | enteric neuron |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0007011 | enteric neuron | Exact |
| Cell Ontology | CL:4040002 | enteroglial cell | Exact |
Enteric neurons are highly diverse in morphology and function, classified into several subtypes:
Molecular Markers:
The ENS operates largely independently of central nervous system input, though it receives modulatory input via the vagus nerve and spinal afferents. The myenteric plexus primarily controls motility patterns, while the submucosal plexus regulates mucosal function[^3].
Enteric neurons produce diverse neurotransmitters:
The Gut-Brain Axis plays a significant role in Parkinson's Disease pathogenesis:
α-Synuclein Pathology: Enteric neurons accumulate Lewy bodies early in PD progression. α-Synuclein fibrils may originate in the gut and propagate via the vagus nerve to the brainstem and substantia nigra[^4].
Gastrointestinal Dysfunction: Constipation and other GI symptoms often predate motor symptoms by years, reflecting ENS involvement.
Microbiome Alterations: PD patients show altered gut microbiota that may influence α-synuclein aggregation and neuroinflammation[^5].
Enteric Glia: Enteric glial cells show α-synuclein pathology and may contribute to disease spread.
Gut-Brain Signaling: ENS dysfunction may contribute to AD through:
neuroinflammation: Gut inflammation can prime peripheral immune cells and exacerbate brain neuroinflammation[^6].
Metabolic Links: ENS dysfunction affects nutrient sensing and may influence type 3 diabetes (brain insulin resistance).
GI Dysmotility: ALS patients frequently experience gastrointestinal complications, including delayed gastric emptying and constipation[^7].
Microbiome Changes: Altered gut microbiota in ALS patients may affect disease progression.
Nutritional Support: Enteric neuron dysfunction impacts nutrition, a critical factor in ALS care.
Autonomic Failure: MSA involves profound autonomic dysfunction, including gastrointestinal dysmotility, reflecting ENS pathology.
α-Synuclein: Enteric neurons show Lewy pathology in MSA, similar to PD.
GI Dysfunction: HD patients exhibit gastrointestinal symptoms, including swallowing difficulties and constipation.
Huntingtin Expression: Mutant huntingtin is expressed in enteric neurons, potentially causing direct toxicity.
Single-cell RNA sequencing has identified multiple enteric neuron subtypes[^8]:
Neuronal Subtypes:
Glial Subtypes:
Disease-Associated Genes Expressed:
Vagus Nerve Stimulation: May modulate ENS function
** GLP-1 Receptor Agonists**: Show promise in PD (exenatide trials)
Targeted Delivery: Nasal or vagal drug delivery to CNS
Gut-Brain Axis
Microbiome
Vagus Nerve
This section links to atlas resources relevant to this cell type, including Allen transcriptomic references.
The study of Enteric Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.